[Form 4] Johnson & Johnson Insider Trading Activity
Marillyn A. Hewson, a director of Johnson & Johnson (JNJ), acquired 280.788 Deferred Share Units (DSUs) on 09/09/2025 under the company's Amended and Restated Deferred Fee Plan for Directors. The DSUs were recorded at a per-unit value of $178.07 and will be settled in cash upon termination of the reporter's directorship. The reported DSUs include accrued dividend equivalent rights tied to the issuer's quarterly dividend. Following the transaction the reporting person’s total DSU exposure is shown as 13,816.8727 units.
- Acquisition of 280.788 DSUs demonstrates continued participation in the issuer's director compensation plan
 - DSUs include dividend equivalents, preserving economic parity with shareholders without immediate share issuance
 
- None.
 
Insights
TL;DR: Routine director compensation deferral; cash-settled DSUs align pay timing with long-term service and reduce share dilution.
The filing documents a standard deferral election under the issuer’s director deferred fee plan. Acquisition of 280.788 DSUs on 09/09/2025 is a non-market transaction coded as an acquisition for deferral of cash retainer. Because DSUs are cash-settled on termination and include dividend equivalents, this conserves outstanding common stock while preserving economic alignment with shareholder returns.
TL;DR: Director converted cash retainer into DSUs valued at $178.07 each; transaction is compensatory rather than open-market trading.
The record shows 280.788 DSUs were acquired at a reported per-unit value of $178.07 and will be paid in cash upon cessation of directorship. Inclusion of dividend equivalents increases the effective economic value of the DSUs. This is a routine, administratively driven transaction and does not represent an equity purchase or sale in the open market.